Biotech Massively Bid Up Premarket

Biotech Massively Bid Up Premarket

By: Tomas Ronolski - AllPennyStocks.com News

Tuesday, January 31, 2023

A New Jersey-based biotech company is turning heads Tuesday morning after the company announced the signing an exclusive option agreement with Dana-Farber Cancer Institute to license technology targeting the MUC1-C oncoprotein.

This sent shares of Hillstream BioPharma Inc. (Nasdaq:HILS) soaring during premarket trade on Tuesday as shares are currently bid up at $1.32/share (+96.72% implied open for sellers) at the time of writing. This move will be a strong continuation of the success this stock has had so far this year. 

Hillstream BioPharma Inc is a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron-mediated cell death for drug-resistant and devastating cancers.


Copyright © 2023 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Canadian Inflation Moves Up as Expected But Easing Underlying Pressures Boost Hopes of June Rate Cut
Shares Up as Firm Launches First Short Spot Bitcoin ETP in the Nordics
Could This Stock Be The Next Big Mover In The Short-Term Rental Market?
Most Popular
FREE Newsletter
AllPennyStocks.com Favorites


Back to Top